Thomas E. D'Ambra Ph.D., Director at ALBANY MOLECULAR RESEARCH INC (AMRI), sold 20,000 shares at $16.24 ($325K) on 2014-12-10, disclosed to the SEC on 2014-12-11.
Scheduled sale ($325k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AMRI | SELL | 2015-04-14 | $370K | — | Filing → |
| AMRI | SELL | 2015-03-11 | $353K | — | Filing → |
| AMRI | SELL | 2015-02-12 | $338K | — | Filing → |